Background Glioblastoma (GBM) is the most common malignant primary brain tumour and confers a very poor prognosis. Maximal safe resection of tumour is the goal of neurosurgical intervention and may be more easily achieved through the use of surgical adjuncts such as fluorescence-guided surgery (FGS). 5-Aminolevulinic acid (5-ALA) accumulates in GBM tissue and fluoresce red, distinguishing tumour cells from the surrounding tissue and therefore making resection easier.
View Article and Find Full Text PDFStudy Design: A multicenter cross-sectional analytical retrospective study.
Purpose: To assess functional outcome (FO) after a spinal meningioma (SM) surgery.
Overview Of Literature: All studies report functional improvement after SM removal.
Study Design: This is a cross-sectional nationwide descriptive observational and analytic retrospective study.
Purpose: This study aims to describe and assess survival after spinal meningioma (SM) surgery.
Overview Of Literature: A few studies report a reduced survival after SM surgery.
Background: Studies on meningioma are reported with inadequate allowance for competing causes of progression or death. The aim of this study was to describe the outcome of patients with intracranial WHO grade I meningioma and identify factors that may influence disease progression and cause-specific survival.
Methods: Pathology reports and clinical data of 505 WHO grade I meningiomas treated between January 2003 and December 2017 were retrospectively reviewed at a single institution.
Background: In contrast to benign meningiomas, malignant meningiomas (MM) are rare and associated with an unfavourable prognosis. Reports on MM concern fairly small cohorts, often comprising less than 30 cases.
Objective: To describe the outcome MM and identify factors that may influence survival.
Nutr Clin Pract
August 2013